# NeuralMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuralmed

- Industry: Software
- Headquarters: Sao Paulo, Brazil
- Website: www.neuralmed.ai
- Total disclosed funding: $1.9M
- Latest round: Series A (Nov 16, 2022)
- Investors on record: 2

## About

NeuralMed, based in Brazil, specializes in AI-powered healthcare solutions that enhance patient triage and improve medical decision-making processes for healthcare providers.Founded in 2018 in Sao Paulo, Brazil, NeuralMed develops advanced healthcare technology, focusing primarily on optimizing patient triage. The company raised BRL 10 million in Series A funding on November 16, 2022, led by Good Karma Partners, with participation from Kortex Ventures. The firm has completed a total of 3 deals to date.NeuralMed offers advanced artificial intelligence-driven solutions designed to optimize patient triage and enhance healthcare delivery. Their core product, the Atlas Finder, enables healthcare providers to identify high-risk patients—specifically those with suspicious pulmonary and breast nodules—by analyzing medical reports and examination results. The technology unifies and processes data from various sources, creating predictive models that facilitate timely interventions, ultimately improving patient outcomes. NeuralMed's offerings cater to a broad client base including over 200 hospitals and healthcare systems, primarily across Brazil, with aspirations for expansion into other Latin American markets. The end users of these services include healthcare professionals who leverage the insights generated by NeuralMed's solutions to streamline workflows and enhance the quality of care provided to patients.NeuralMed's revenue is generated through partnerships and subscriptions with healthcare providers, leveraging a business-to-business (B2B) model. Clients typically engage NeuralMed by subscribing to its software solutions, which include the Atlas Finder and the Atlas Tracker, both designed to support patient identification and care management. The revenue structure is based on service agreements that may include initial setup fees and recurring subscription costs for continued access to the software, support services, and ongoing updates. The pricing structure varies according to the scale of implementation and the specific needs of healthcare providers, ensuring that each client can adopt the solutions that best fit their operational requirements while enhancing patient care efficiency.Following its Series A funding round on November 16, 2022, where NeuralMed raised BRL 10 million to further develop its portfolio and product, the company plans to enhance its existing solutions and introduce new products tailored for diverse healthcare settings. Additionally, NeuralMed aims to expand its market reach into other Latin American countries, leveraging the recent investment to support this growth strategy.

## Funding rounds

- Series A, Nov 16, 2022, $1.9M — Good Karma Partners, Kortex Ventures

## Investors

- Good Karma Partners (https://capitalatlas.ai/funds/good-karma-partners) — Series A
- Kortex Ventures (https://capitalatlas.ai/funds/kortex-ventures) — Series A